TA Associates Completes Strategic Growth Investment in Vee Healthtek
November 18, 2024
TA Associates completed a strategic growth investment in Vee Healthtek to support the company's expansion of technology-enabled services for healthcare organizations. The partnership will help Vee Healthtek enhance its technology capabilities, expand offerings (organically and via M&A) across revenue cycle management, health information management, analytics, risk adjustment and claims management; financial terms were not disclosed.
- Buyers
- TA Associates
- Targets
- Vee Healthtek
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Varsity Healthcare Partners Makes Growth Investment in Trialbee
January 7, 2026
Healthcare Services
Varsity Healthcare Partners completed a strategic growth investment in Trialbee, a Sweden-headquartered, technology-enabled provider of patient recruitment services and analytics for clinical trials. VHP will partner with Trialbee's management to accelerate commercial scale, technology innovation, and global delivery capabilities while Trialbee's CEO Matt Walz remains in place; financial terms were not disclosed.
-
Vee Healthtek Acquires Precision Practice Management
September 29, 2025
Healthcare Services
Vee Healthtek, an AI-enabled healthcare technology and services provider headquartered in Plano, Texas, has acquired Precision Practice Management, a St. Louis-based revenue cycle and practice management services firm. The deal expands Vee Healthtek's ambulatory market footprint and technology-enabled revenue cycle capabilities to deliver broader practice management, billing, coding and consulting services to healthcare providers.
-
TA Associates Makes Strategic Growth Investment in HealthMark Group
July 30, 2025
Healthcare Services
TA Associates has made a strategic growth investment in HealthMark Group, a Dallas-based provider of clinical information exchange solutions. Management and existing investor Ridgemont Equity Partners rolled meaningful stakes as TA becomes the new lead investor to accelerate HealthMark's growth, expand capabilities, and broaden market reach.
-
TA Associates Makes Growth Investment in Vastu Housing Finance
July 11, 2024
Financial Services
TA Associates has made a strategic growth investment in Vastu Housing Finance, a Mumbai-based, technology-led affordable housing finance company serving self‑employed customers across semi-urban and rural India. The investment will support Vastu's expansion across its mortgage, small business and used vehicle finance businesses; financial terms were not disclosed.
-
TA Associates Makes Strategic Growth Investment in Diatech Pharmacogenetics
April 26, 2023
Biotechnology
TA Associates has signed a definitive agreement to make a strategic growth investment in Diatech Pharmacogenetics, a Jesi, Italy–based developer and manufacturer of molecular diagnostics for precision oncology. Minority investor Alto Partners will fully exit while Diatech's founder and management retain majority ownership; the capital will support product development and international expansion.
-
TA Associates Makes Growth Investment in Veracode
March 15, 2022
Cybersecurity
TA Associates has signed a definitive agreement to make a significant growth investment in Veracode, valuing the application security company at $2.5 billion. Current majority investor Thoma Bravo will retain a minority stake; the deal is expected to close in Q2 2022 and will fund Veracode's product expansion, strategic M&A, and global growth initiatives.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.